Blistering Papulosquamous Erythema with Arthralgia: A Quiz


  • Yukiho Kurosaki
  • Yosuke Ishitsuka Osaka University
  • Yasuhiro Kato
  • Noriko Arase
  • Manabu Fujiomto



Abstract is missing (Quiz)


Download data is not yet available.


Hubner F, Langan EA, Recke A. Lichen planus pemphigoides: from lichenoid inflammation to autoantibody-mediated blistering. Front Immunol 2019; 10: 1389.

Zillikens D, Caux F, Mascaro JM, Wesselmann U, Schmidt E, Prost C, et al. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180. J Invest Dermatol 1999; 113: 117-121.

Gawkrodger DJ, Stavropoulos PG, McLaren KM, Buxton PK. Bullous lichen planus and lichen planus pemphigoides - clinico-pathological comparisons. Clin Exp Dermatol 1989; 14: 150-153.

Yamashita C, Arase N, Higuchi S, Arase H, Takagi J, Nojima S, et al. Serum autoantibodies against the extracellular region of alpha6beta4 integrin in a patient with dipeptidyl peptidase-4 inhibitor-induced bullous pemphigoid. JAAD Case Rep 2022; 20: 65-68.

Liu Y, Soh WT, Kishikawa JI, Hirose M, Nakayama EE, Li S, et al. An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies. Cell 2021; 184: 3452-3466.e8.

Tomayko MM, Damsky W, Fathy R, McMahon DE, Turner N, Valentin MN, et al. Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination. J Allergy Clin Immunol 2021; 148: 750-751.

Sato NA, Kano Y, Shiohara T. Lichen planus occurring after influenza vaccination: report of three cases and review of the literature. Dermatology 2010; 221: 296-299.

Rebora A, Rongioletti F, Drago F, Parodi. Lichen planus as a side effect of HBV vaccination. Dermatology 1999; 198: 1-2.

Laschinger ME, Schleichert RA, Green B. Lichenoid drug eruption after human papillomavirus vaccination. Pediatr Dermatol 2015; 32: e48-e49.

Farinazzo E, Ponis G, Zelin E, Errichetti E, Stinco G, Pinzani C, et al. Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from Northeast Italy. J Eur Acad Dermatol Venereol 2021; 35: e548-e551.

Larson V, Seidenberg R, Caplan A, Brinster NK, Meehan SA, Kim RH. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination. J Cutan Pathol 2022; 49: 34-41.

Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med 2020; 383: 2603-2615.

Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol 2020; 217: 108480.

Witberg G, Barda N, Hoss S, Richter I, Wiessman M, Aviv Y, et al. Myocarditis after covid-19 vaccination in a large health care organization. N Engl J Med 2021; 385: 2132-2139.

Iketani S, Liu L, Nair MS, Mohri H, Wang M, Huang Y, et al. A third COVID-19 vaccine shot markedly boosts neutralizing antibody potency and breadth. medRxiv 2021.


Additional Files



How to Cite

Kurosaki, Y., Ishitsuka, Y., Kato, Y. ., Arase, N., & Fujiomto, M. (2022). Blistering Papulosquamous Erythema with Arthralgia: A Quiz. Acta Dermato-Venereologica, 102, adv00690.